the canadian cardiovascular society data dictionary · the core elements and demographics data...

THE CANADIAN CARDIOVASCULAR SOCIETY DATA DICTIONARY

A CCS Consensus Document

CORE ELEMENTS AND DEMOGRAPHICS DATA ELEMENTS AND DEFINITIONS

FINAL Version 1.1

Last Updated: July 6, 2012

Copyright © 2012 The Canadian Cardiovascular Society This publication may not be reproduced or modified without the permission of The Canadian Cardiovascular Society.

For authorised reproduction, please obtain permission from:

The Canadian Cardiovascular Society 222 Queen Street, Suite 1403 Ottawa, Ontario Canada K1P 5V9

Email: [email protected]

Core Elements and Demographics Data Elements and Definitions

The Canadian Cardiovascular Society Data Dictionary

FINAL V1.1 – JULY 2012

2

Background The Canadian Cardiovascular Society Data Dictionary is comprised of multiple "chapter" data elements and definitions

that reflect national input and consensus on definitions within several spheres cardiovascular disease, treatment and

subspecialty expertise

The Core Elements and Demographics data dictionary chapter contains the guidelines for data elements and definitions

that includes the collection of information specific to demographics, history and risk factors, co-morbidities, test results,

symptoms and medications. The Core Elements and Demographics data elements and definitions should be used as a

base and adopted first by any new/existing cardiovascular registry.

Revision History

V1.1 – June 19, 2012 1) Revision - page 4Old data element name: Health Card Number Revised data element name: Health Care Number

A note was appended to indicate that the Health Care Number should be stored unencrypted in order to allow linkage to CIHI.

2) NEW addition - page 4Data element name: Province/Territory issuing HCN Data definitions: Represents the provincial/territorial government from which the health care number was issued.

3) REVISED Birth date data element - page 5Added: For unknown or estimated birthdate code as 99990901




3

TABLE OF CONTENTS

PART 1 – DEMOGRAPHICS ................................................................................................................ 4

PART 2 – HISTORY & RISK FACTORS .............................................................................................. 7

PART 3 – CO-MORBIDITIES ............................................................................................................... 9

PART 4 – TEST RESULTS ................................................................................................................ 11

PART 5 – SYMPTOMS ....................................................................................................................... 12

PART 6 – MEDICATIONS .................................................................................................................. 14

A. Medications at Pre-Encounter .................................................................................................................. 14

B. Medications during Healthcare Encounter ............................................................................................... 17

C. Medications at Discharge ........................................................................................................................ 20

ACKNOWLEDGEMENT ..................................................................................................................... 24

Data Definitions Core Elements and Demographics Chapter Working Group .............................................. 24

Data Definitions Steering Committee ........................................................................................................... 24

DISCLAIMER ...................................................................................................................................... 25

COPYRIGHT ....................................................................................................................................... 25




4

PART 1 – DEMOGRAPHICS DATA ELEMENT CLASSIFICATION DEFINITION

First Name Middle Initial Last Name

CORE1 Indicate the patient's first, middle initial, and last name.

Hyphenated names should be recorded with a hyphen.

Maiden Name CORE1 If the patient is female and married, record the patient’s maiden name

Health Care Number CORE1 Indicate the patient’s health care number.

Note: must be stored unencrypted in order to allow linkage to CIHI.

Province/Territory Issuing HCN

CORE Represents the provincial/territorial government from which the Health Care Number was issued.

1. AB (Alberta)

2. BC (British Columbia)

3. MB (Manitoba)

4. NB (New Brunswick)

5. NL (Newfoundland and Labrador)

6. NT (Northwest Territories)

7. NS (Nova Scotia)

8. NU (Nunavut)

9. ON (Ontario)

10. PE (Prince Edward Island)

11. QC (Quebec)

12. SK (Saskatchewan)

13. YT (Yukon)

14. 99 (Use when a patient is out of province/territory/country)

15. CA (Canada – RCMP, penitentiary inmates, Veteran Affairs Canada et cetera; used when patient has a federal Health Care Number)

Note: consistent with CIHI Discharge Abstract Database (DAD) definitions for ‘’Province/Territory issuing HCN’

Chart Number CORE The chart number assigned by the reporting facility to all patients.

Field length is up to and including 10 characters (alphanumeric or numeric).

1 The collection of this information may be restricted by the privacy act of the provincial/territorial jurisdiction or may be omitted by

design of the original database.




5

Institution ID CORE Indicate the Institution number.

This is a five digit unique number assigned by the province/territory ministry of health to identify the facility and the level of care provided.

NOTE: Use of CIHI institution codes is recommended.

Birth Date CORE Indicate the patient’s date of birth date in this format: YYYYMMDD2.

For unknown or estimated birthdate, code as ‘99990901’

Sex CORE Indicate the patient’s sex by selecting one of the following:

1. Male

2. Female

3. Undetermined (undifferentiated used only for stillborn cases and

where the sex cannot be determined)

4. Other (trans-sexual or hermaphrodite), if possible, specify (optional

to specify)

Note: consistent with CIHI Discharge Abstract Database (DAD) definitions for ‘Gender’

Race CORE Indicate the patient’s race from the following (multiple responses accepted):

Note: for mixed races, select all that apply.

1. Aboriginal (includes Inuit, Métis peoples of Canada, First Nations -

North American Indian)

2. Arab (includes Egyptian, Kuwait, Libyan)

3. West Asian (includes Afghan, Assyrian and Iranian)

4. Black (includes African, Nigerian, Somali)

5. Chinese

6. Filipino

7. Japanese

8. Korean

9. Latin American (includes Chilean, Costa Rican, Mexican)

10. South Asian (includes Bangladeshi, Punjabi, Sri Lankan)

11. South East Asian (includes Vietnamese, Cambodian, Malaysian,

Laotian)

12. White (Caucasian)

13. Other, if possible, specify (optional to specify)

Postal Code CORE Indicate the patient’s postal code. It consists of six alphanumeric characters in ANA-NAN sequence.

2 This is the standard European format for dates and also follows the CIHI Discharge Abstract Database (DAD) for dates. All data

elements across all chapters should consistently use the YYYYMMDD format.




6

Employment Status OPTIONAL Indicate which one of the following categories best describes the patient’s current employment status:

Note: Participation in the labour market takes precedence e.g. code as ‘part-time’ if an individual is both a student and is employed part-time.

1. Employed full-time, that is, 35 or more hours per week

2. Employed part-time, that is, less than 35 hours per week

3. Self-employed (primary occupation)

4. Unemployed, but looking for work

5. Student

6. Retired

7. Not in the paid workforce (homemaker, unemployed, not looking for

work)

Marital Status CORE Indicate which one of the following categories best describes the patient’s current marital status:

1. Single

2. Married or equivalent (i.e. common law, same sex)

3. Separated or equivalent

4. Divorced

5. Widowed

Education Level CORE Indicate the highest level of education the patient has attained:

1. Less than high school (no certificates, diplomas or degrees)

2. High school graduation certificate

3. Trades certificate

4. College certificate or diploma: a certificate from a community

college, CEGEP, school of nursing, theological college or private

college

5. University: a certificate below the bachelor level, bachelor’s degree,

certificate above the bachelor level, master’s degree, earned

doctorate or a professional degree in medicine, dentistry, veterinary

medicine or optometry.




7

PART 2 – HISTORY & RISK FACTORS FIELD NAME CLASSIFICATION DEFINITION

Height CORE Indicate the patient's height in centimetres (cm)

Weight CORE Indicate the patient's weight in kilograms (kg)

Smoking Status/History

CORE 1. Never = no history of any form of tobacco 2. Current = use of any form of tobacco (cigarettes, cigar, pipe) within

one month of referral date

3. Former = use of any form of tobacco > one month of referral date.

Hypertension CORE Patient has a documented history

3 of hypertension diagnosed and/or

treated by a healthcare provider. Treatment may include medication, diet and/or exercise.

1. Yes 2. No 3. Unknown

Dyslipidemia CORE Patient has a documented history of dyslipidemia diagnosed

and/or treated by a physician.

1. Yes

2. No

3. Unknown

Family History of premature Coronary Artery Disease (CAD)

CORE Patient has/had any direct blood relative (parents, siblings, and children)

who have been diagnosed with angina, MI, PCI, CABG or sudden cardiac

death for male relatives before age 55 years or for female relatives before

age 65 years.

1. Yes

2. No

3. Unknown

History of MI CORE Patient has had at least one documented history of MI. NOTE: History

4 of

MI should be coded "yes" only for MIs that occurred prior to the first onset of symptoms that led to this episode of care. Code No if the patient's only MI occurred at any transferring facility.

1. Yes 2. No

3. Unknown

History of Angina CORE Patient has a documented history of angina diagnosed and/or treated by a physician.


3 ‘documented history’ means the patient has been told by a physician that they clearly have this diagnosis or there is a medical

record of this diagnosis.

4 ‘history’ is a patient provided history




8

History of Heart Failure

CORE Patient has a documented history of heart failure diagnosed and/or treated by a physician.

1. Yes 2. No

Unknown

History of Atrial Fibrillation/Flutter

CORE Patient has a documented history of atrial fibrillation or flutter.


Prior Valve Surgery/Procedure

CORE Patient has had a previous surgical replacement and/or repair of a cardiac

valve, by any approach prior to this episode of care.

1. Yes

2. No

3. Unknown

Prior PCI CORE Patient has had a previous PCI. This includes any attempted PCI whether successful or not prior to this episode of care.


Prior CABG CORE Patient has had a previous coronary artery bypass graft (CABG) prior to this episode of care.


Other Cardiac Procedures

OPTIONAL Patient has had a documented history of cardiovascular procedure(s) prior

to this episode of care.

1. Yes. If yes, select the type of procedure(s) a. cardiac transplantation b. other vascular surgery, if possible, specify (optional to

specify) c. pacemaker (permanent) d. ICD e. other cardiac surgery (cardiac embolectomy, valvular

surgery), if possible, specify (optional to specify) f. No g. Unknown

NOTE: Amputations for PVD and varicose vein stripping are not

considered “other vascular surgery”.

Prior Cardiac Arrest OPTIONAL Patient has had a documented history of a v-fib, cardiac arrest or previous CPR secondary to a cardiac cause. (ex. Ischemia, arrhythmia). NOTE: A sinus arrest is not a cardiac arrest.


Diabetes (Mellitus) Note: This data element is captured in the co-morbidities section that

follows.




9

PART 3 – CO-MORBIDITIES FIELD NAME CLASSIFICATION DEFINITION

(Includes any occurrence between birth and this episode of care, unless otherwise indicated.

Dialysis CORE Patient is currently undergoing either hemodialysis or peritoneal dialysis as a result of renal failure.


Prior Transplant CORE Patient has a documented history of solid organ transplants.

1. Yes. If yes, select from any of the following (multiple responses accepted)

a. Heart (included heart or heart lung) b. Kidney c. Other, if possible, specify (optional to specify)

2. No 3. Unknown

Prior Cerebrovascular Disease

CORE Patient has a documented history of cerebral vascular disease documented as any history of stroke, TIA, previous carotid endarterectomy/stent or any known carotid stenosis > = 70%


Prior Cerebrovascular Accident CVA/Stroke

OPTIONAL Patient has a documented history of cerebrovascular accident (CVA)/stroke as evidenced by a persistent neurological deficit.


Peripheral Arterial Disease

CORE Patient has a documented history of peripheral arterial disease (includes upper and lower extremity, renal, mesenteric, and abdominal aortic systems). This can include claudication, either with exertion or at rest, positive non-invasive/invasive test, documented aortic aneurysm, or prior corrective surgery, angioplasty or amputation to the extremities.


COPD CORE Patient has a documented history of chronic obstructive lung disease. Chronic obstructive lung disease (excluding isolated asthma) can include patients with chronic obstructive pulmonary disease, chronic bronchitis, or emphysema.





10

Diabetes (Mellitus) CORE Patient has documented history of diabetes mellitus diagnosed and /or treated by a physician prior to admission.

1. Yes. If yes, indicate diabetes control.(select more than one if applicable):

a. None b. Diet c. Oral d. Insulin e. Non-insulin injectables f. Other, if possible, specify (optional to specify)

2. No 3. Unknown




11

PART 4 – TEST RESULTS FIELD NAME CLASSIFICATION DEFINITION

(LV) function CORE Provide the most recent estimated or calculated left ventricular (LV)

function, as the percentage of blood emptied from the left ventricle at the

end of the contraction.

Enter actual number, if available:

If actual number not available, select the appropriate category (category

source: CARDS):

1. Normal (>50%)

2. Slightly reduced (41-50%)

3. Moderately reduced (31-40%)

4. Severely reduced (<30%)

5. LV function not assessed

6. Unknown

Indicate the method used:

1. Echocardiography

2. LV-Gram

3. SPECT / PET

4. MUGA

5. CT/MR

6. Other, if possible, specify (optional to specify)

Creatinine and/or eGFR

CORE Indicate most recent value

1. Creatinine

2. eGFR (provide method for estimation of GFR)

a. Cockcroft-Gault

b. Modified MDRD

c. Other, please specify




12

PART 5 – SYMPTOMS FIELD NAME CLASSIFICATION DEFINITION

CCS Angina Class CORE Select the CCS Angina classification and indicate the point in time:

1. Class 0 Asymptomatic

a. Current (at time of collection/seeking medical care) b. Worst c. Other, please specify

2. Class I Ordinary physical activity, such as walking or climbing stairs does not cause angina. Angina with strenuous, rapid, or prolonged exertion at work or recreation.


3. Class II Slight limitation of ordinary activity. Walking or climbing stairs rapidly, walking uphill, walking or stair climbing after meals, or in cold or in wind or under emotional stress, or only during the few hours after awakening. Walking more than two blocks on the level or climbing more than one flight of ordinary stairs at a normal pace and under normal conditions.

a. Current (at time of collection/seeking medical care) b. Worst

c. Other, please specify 4. Class III

Marked limitation of ordinary physical activity. Walking one or two blocks on the level or climbing one flight of stairs in normal conditions and at a normal pace.


5. Class IV Inability to carry our any physical activity without discomfort - anginal syndrome may be present at rest.






13

NYHA Functional Capacity

CORE Select the NYHA classification and indicate the point in time:

1. Class I Patients with cardiac disease but without resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or anginal pain.


c. Other, please specify 2. Class II

Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.


c. Other, please specify 3. Class III

Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or anginal pain.


c. Other, please specify 4. Class IV

Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.






14

PART 6 – MEDICATIONS

A. Medications at Pre-Encounter

DATA ELEMENT CLASSIFICATION DEFINITION

Aspirin at Pre-Encounter

CORE Indicate if the patient has been taking Aspirin routinely prior to this encounter.

1. Yes 2. No 3. Contraindicated 4. Blinded

Clopidogrel at Pre-Encounter

CORE Indicate if the patient has been taking Clopidogrel routinely prior to this encounter.


Prasugrel at Pre-Encounter

CORE Indicate if the patient has been taking Prasugrel routinely prior to this encounter.


Ticagrelor at Pre-Encounter

CORE Indicate if the patient has been taking Ticagrelor routinely prior to this encounter.


Other anti-platelets (eg. ticlopidine) at Pre-Encounter

CORE Indicate if the patient has been taking other anti-platelets (eg. Ticlopidine) routinely prior to this encounter.


Warfarin at Pre-Encounter

CORE Indicate if the patient has been taking Warafin routinely prior to this encounter.


Other oral anti-coagulants (eg. dabigatran, rivaroxiban) at Pre-Encounter

CORE Indicate if the patient has been taking other anti-coagulants (eg. Dabigatran, rivaroxiban) routinely prior to this encounter.


Unfractionated heparin at Pre-Encounter

CORE Indicate if the patient has been taking unfractionated heparin routinely prior to this encounter.





15

LMW heparin at Pre-Encounter

CORE Indicate if the patient has been taking LMW heparin routinely prior to this encounter.


Beta Blockers at Pre-Encounter

CORE Indicate if the patient has been taking beta-blockers routinely prior to this encounter.


ACE Inhibitors / Angiotensin II Receptor Blockers at Pre-Encounter

CORE Indicate if the patient has been taking ACE inhibitors/Angiotensin II Receptor blockers routinely prior to this encounter.


Aldosterone Blocking Agents at Pre-Encounter

CORE Indicate if the patient has been taking Aldosterone blocking agents routinely prior to this encounter.


Direct renin inhibitors at Pre-Encounter

CORE Indicate if the patient has been taking Direct renin inhibitors routinely prior to this encounter.


Statins at Pre-Encounter

CORE Indicate if the patient has been taking Statins routinely prior to this encounter.


Other lipid lowering agents at Pre-Encounter

CORE Indicate if the patient has been taking other lipid lowering agents routinely prior to this encounter.


Diuretics (excluding spironolactone, epleronone) at Pre-Encounter

CORE Indicate if the patient has been taking Diuretics (Excluding spironolactone, epleronone) routinely prior to this encounter.


Insulin at Pre-Encounter

CORE Indicate if the patient has been taking Insulin routinely prior to this encounter.





16

Oral antihyperglycemics at Pre-Encounter

CORE Indicate if the patient has been taking oral antihyperglycemics routinely prior to this encounter.


Non-insulin injectables at Pre-Encounter

CORE Indicate if the patient has been taking Non-insulin injectables routinely prior to this encounter.


Dihydropyridine Calcium Channel Blockers at Pre-Encounter

CORE Indicate if the patient has been taking dihydropyridine calcium channel blockers routinely prior to this encounter.


Non-dihydropyridine Calcium Channel Blockers at Pre-Encounter

CORE Indicate if the patient has been taking non-dihydropyridine calcium channel blockers routinely prior to this encounter.


Anti-arrhythmics at Pre-Encounter

CORE Indicate if the patient has been taking anti-arrhythmics routinely prior to this encounter.


Digoxin at Pre-Encounter

CORE Indicate if the patient has been taking Digoxin routinely prior to this encounter.





17

B. Medications during Healthcare Encounter


Aspirin during Healthcare Encounter

CORE Indicate if Aspirin was administered at any point in time during this episode of health care.


Clopidogrel during Healthcare Encounter

CORE Indicate if Clopidogrel was administered at any point in time during this episode of health care.


Prasugrel during Healthcare Encounter

CORE Indicate if Prasugrel was administered at any point in time during this episode of health care.


Ticagrelor during Healthcare Encounter

CORE Indicate if Ticagrelor was administered at any point in time during this episode of health care.


Other anti-platelets (eg. ticlopidine) during Healthcare Encounter

CORE Indicate if other anti-platelets (eg. Ticlopidine) were administered at any point in time during this episode of health care.


Warfarin during Healthcare Encounter

CORE Indicate if Warfarin was administered at any point in time during this episode of health care.


Other oral anti-coagulants (eg. dabigatran, rivaroxiban) during Healthcare Encounter

CORE Indicate if other oral anti-coagulants (eg. dabigatran, rivaroxiban) were administered at any point in time during this episode of health care.


Unfractionated heparin during Healthcare Encounter

CORE Indicate if Unfractionated heparin was administered at any point in time during this episode of health care.





18

LMW heparin during Healthcare Encounter

CORE Indicate if LMW heparin was administered at any point in time during this episode of health care.


Beta Blockers during Healthcare Encounter

CORE Indicate if Beta-Blockers were administered at any point in time during this episode of health care.


ACE Inhibitors/Angiotensin II Receptor Blockers during Healthcare Encounter

CORE Indicate if ACE Inhibitors/Angiotensin II Receptor blockers were administered at any point in time during this episode of health care.


Aldosterone Blocking Agents during Healthcare Encounter

CORE Indicate if Aldosterone Blocking Agents were administered at any point in time during this episode of health care.


Direct renin inhibitors during Healthcare Encounter

CORE Indicate if Direct renin inhibitors were administered at any point in time during this episode of health care.


Statins during Healthcare Encounter

CORE Indicate if Statins were administered at any point in time during this episode of health care.


Other lipid lowering agents during Healthcare Encounter

CORE Indicate if other lipid lowering agents were administered at any point in time during this episode of health care.


Diuretics (excluding spironolactone, epleronone) during Healthcare Encounter

CORE Indicate if Diuretics were administered at any point in time during this episode of health care.


Insulin during Healthcare Encounter

CORE Indicate if Insulin was administered at any point in time during this episode of health care.





19

Oral antihyperglycemics during Healthcare Encounter

CORE Indicate if oral antihyperglycemics were administered at any point in time during this episode of health care.


Non-insulin injectables during Healthcare Encounter

CORE Indicate if Non-insulin injectables were administered at any point in time during this episode of health care.


Dihydropyridine Calcium Channel Blockers during Healthcare Encounter

CORE Indicate if dihydropyridine calcium channel blockers were administered at any point in time during this episode of health care.


Non-Dihydropyridine Calcium Channel Blockers during Healthcare Encounter

CORE Indicate if non-dihydropyridine calcium channel blockers were administered at any point in time during this episode of health care.


Anti-arrhythmics during Healthcare Encounter

CORE Indicate if Anti-arrhythmics were administered at any point in time during this episode of health care.


Digoxin during Healthcare Encounter

CORE Indicate if Digoxin was administered at any point in time during this episode of health care.





20

C. Medications at Discharge


Aspirin at Discharge CORE Indicate if Aspirin was continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Clopidogrel at Discharge

CORE Indicate if Clopidogrel was continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Prasugrel at Discharge

CORE Indicate if Prasugrel was continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Ticagrelor at Discharge

CORE Indicate if Ticagrelor was continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Other anti-platelets (eg. ticlopidine) at Discharge

CORE Indicate if other anti-platelets were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Warfarin at Discharge

CORE Indicate if Warfarin was continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Other oral anti-coagulants (eg. dabigatran, rivaroxiban) at Discharge

CORE Indicate if other oral anti-coagulants (eg. dabigatran, rivaroxiban) were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital





21

Unfractionated heparin at Discharge

CORE Indicate if Unfractionated heparin was continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


LMW heparin at Discharge

CORE Indicate if LMW heparin was continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Beta Blockers at Discharge

CORE Indicate if Beta-Blockers were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


ACE Inhibitors/Angiotensin II Receptor Blockers at Discharge

CORE Indicate if ACE Inhibitors/Angiotensin II Receptor Blockers were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Aldosterone Blocking Agents at Discharge

CORE Indicate if Aldosterone Blocking Agents were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Direct renin inhibitors at Discharge

CORE Indicate if Direct renin inhibitors were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Statins at Discharge CORE Indicate if Statins were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital





22

Other lipid lowering agents at Discharge

CORE Indicate if other lipid lowering agents were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Diuretics (excluding spironolactone, epleronone) at Discharge

CORE Indicate if Diuretics (excluding spironolactone, eplerone) were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Insulin at Discharge CORE

Indicate if Insulin was continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Oral antihyperglycemics at Discharge

CORE Indicate if Oral antihyperglycemics were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Non-insulin injectables at Discharge

CORE Indicate if Non-insulin injectables were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Dihydropyridine Calcium Channel Blockers at Discharge

CORE Indicate if dihydropyridine calcium channel blockers were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Non-Dihydropyridine Calcium Channel Blockers at Discharge

CORE Indicate if non-dihydropyridine calcium channel blockers were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital





23

Anti-arrhythmics at Discharge

CORE Indicate if Anti-arrhythmics were continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital


Digoxin at Discharge

CORE Indicate if Digoxin was continued or prescribed at Discharge. Note: do not code for patients who die or are AMA or are transferred to another hospital





24

ACKNOWLEDGEMENT The Canadian Cardiovascular Society would like to acknowledge the help and guidance of the following individuals in the

development of the Core Elements and Demographics chapter data elements and definitions:

Data Definitions Core Elements and Demographics Chapter Working Group Karin Humphries (Chair), British Columbia Cardiac Registry

Ross Davies (Vice-Chair), University of Ottawa Heart Institute

Christopher Buller, Hamilton Health Sciences, ON

Jafna Cox, Cardiovascular Health Nova Scotia, NS

Diane Galbraith, Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease, AB

Dennis Ko, Institute for Clinical Evaluative Studies

Laurie Lambert, Agence d’évaluation des technologies et des modes d’intervention en santé

Douglas Lee, Canadian Cardiovascular Outcomes Research Team / Institute for Clinical Evaluative Studies

Anne McFarlane, Canadian Institute for Health Information

Kori Kingsbury, Cardiac Care Network of Ontario

Representatives from the Public Health Agency of Canada

Data Definitions Steering Committee Christopher Buller (Chair), Hamilton Health Sciences, ON

Jafna Cox, Cardiovascular Health Nova Scotia, NS

Ross Davies, University of Ottawa Heart Institute

Diane Galbraith, Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease, AB

Karin Humphries, British Columbia Cardiac Registry

Kori Kingsbury, Cardiac Care Network of Ontario

Dennis Ko, Institute for Clinical Evaluative Studies

Laurie Lambert, Agence d’évaluation des technologies et des modes d’intervention en santé

Anne McFarlane, Canadian Institute for Health Information

Representatives from the Public Health Agency of Canada

Charlie Kerr, Past President, and Blair O’Neill, President, Canadian Cardiovascular Society, ex-officios

Project Support Anne Ferguson, Chief Executive Officer, Canadian Cardiovascular Society

Louise Marcus, Project Director and Director, Health Policy/Advocacy, Canadian Cardiovascular Society

Holly Fan, Project Manager (external)

Production of these materials has been made possible by The Canadian Cardiovascular Society and through a financial

contribution from the Public Health Agency of Canada.




25

DISCLAIMER The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.

COPYRIGHT © All rights reserved. No part of this document may be reproduced, stored in a retrieval system or transmitted in any format or by any means, electronic, mechanical, photocopying, recording or otherwise, without the proper written

permission of The Canadian Cardiovascular Society™.

the canadian cardiovascular society data dictionary · the core elements and demographics data...

Documents